Collections
Patrick Poke

Investing in “blue chips” – large, highly profitable, and mature companies – has long been a popular strategy for investors. But contrary to its popularity, research has shown (i) that the largest stocks consistently underperform over the long-term. Perhaps investors have fallen victim to survivorship bias? Rather than looking at... Show More

Collections
Patrick Poke

What will the world look like in five years’ time? A difficult question to answer, but one that long-term equity investors must ask themselves every day. In 2014, Amazon remained outside the world’s top 10 companies, Telstra’s share price peaked at over $6.60 per share, and Afterpay was nothing more... Show More

Daniel Moore

Over the last 20 years we have seen many of Australia’s larger companies such as Brambles, Woolworths, Fosters, NAB, Woolworths, Orica and Amcor demerge and spin off smaller parts of their business on the stock market. The primary objective for separately listing the demerged company was to allow both the... Show More

Buy Hold Sell

Quality companies are characterised as having good return on equity (ROE), strong earnings growth and low levels of gearing. In this episode of Buy Hold Sell we've identified stocks in the ASX100 that meet these criteria, the challenge now is to see if there's value for investors. Shares in Cochlear, Flight... Show More

Buy Hold Sell

Freely available credit has long helped fund a love affair with property investment, with Australian household leverage up 23 of the last 25 years. Hamish Chalmers from Watermark told us: "Investors in Sydney and Melbourne were taking anywhere between fifty and sixty percent of mortgage flow... that's a witheringly high number.... Show More

Daniel Moore

Australia’s Healthcare sector has outperformed all others over the last five years, due to strong demand from investors seeking companies with reliable earnings growth. This has pushed valuations to historically high levels, with some healthcare companies trading at a 50 per cent premium to their global peers, and a 100... Show More

Thanks Darren. While RMD wasn’t included in this article, we regularly publish Investment insights and views from our Portfolio Managers and PMs. You’re welcome to sign-up to receive these on IML’s website www.iml.com.au and we also post many of these articles on Livewire.

On The best opportunity in healthcare -